(b)(4).Upon evaluation of the returned device, it was noted that no lockwire, stent, tip or polyimide were returned.The red shuttle deployment marker was towards the front of the handle on return.There was a kink in the flexor at the handle which did not impact deployment as deployment and retraction were possible.It was confirmed that the broken piece of device 'was not left inside the patient as the stent deployed but as they thought it hadn¿t they pulled the wire out after completing the procedure but did not keep it.' it was also confirmed that the 2 unused devices returned did not have any complaint associated with them: ¿it was more a precaution than anything.¿ the customer complaint was confirmed on customer testimony; however, as per information provided by the rep this issue was user error.The stent was not placed in the correct position.Product manager has been contact to request that training be provided.Prior to distribution all evo-25-30-10-c devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for evo-25-30-10-c of lot number c1158682 did not reveal any discrepancies that could have contributed to this issue.As per instructions for use, ¿stent should be placed endoscopically with fluoroscopic monitoring." also, ¿confirm desired stent position fluoroscopically and deploy stent by removing red safety guard from the handle.¿ ¿after deployment, fluoroscopically confirm full stent expansion.Once full expansion is confirmed, introduction system can be safely removed.¿ complaints of this nature will continue to be monitored for potential emerging trends.
|